HDAC9 and head and neck squamous cell carcinoma: Whilst broadly, these studies demonstrate the potential for HDAC inhibition to effectively improve the sensitivity of cancer cells to radiotherapy, interestingly, this strategy has not been reportedly explored in HNSCC.